Balchem (NASDAQ:BCPC) will be announcing its earnings results before the market opens on Thursday, February 28th. Analysts expect the company to announce earnings of $0.52 per share for the quarter.
Shares of BCPC opened at $87.92 on Thursday. Balchem has a 12 month low of $73.16 and a 12 month high of $117.79. The firm has a market cap of $2.79 billion, a PE ratio of 34.75 and a beta of 0.91. The company has a current ratio of 3.42, a quick ratio of 2.33 and a debt-to-equity ratio of 0.27.
Several research analysts have recently commented on BCPC shares. Zacks Investment Research lowered shares of Balchem from a “hold” rating to a “sell” rating in a research note on Tuesday, December 11th. ValuEngine lowered shares of Balchem from a “buy” rating to a “hold” rating in a research note on Thursday, November 1st. HC Wainwright set a $101.00 target price on shares of Balchem and gave the company a “buy” rating in a research note on Tuesday, February 5th. BidaskClub lowered shares of Balchem from a “sell” rating to a “strong sell” rating in a research note on Wednesday, November 28th. Finally, Pivotal Research upgraded shares of Balchem from a “hold” rating to a “buy” rating and raised their target price for the company from $95.00 to $100.00 in a research note on Tuesday, November 6th. Four investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Balchem presently has an average rating of “Hold” and a consensus price target of $105.50.
TRADEMARK VIOLATION WARNING: “Balchem (BCPC) to Release Earnings on Thursday” was first posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2019/02/21/balchem-bcpc-to-release-earnings-on-thursday.html.
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Read More: How Short Selling Works
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.